Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Three strengths of pregabalin among third January price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed on concessionary prices for the following 13 items for January 2021 prescriptions.

An initial 18 items were announced on January 15 and a further nine were added to the list on January 25.

*Prochlorperazine 5mg was granted a price concession late on January 29.

 

Drug
Strength
Form
Price
Chlorpromazine
50mg
tablets (28)
£21.29
Esomeprazole
20mg
gastro-resistant tablets (28)
£6.57
Esomeprazole
40mg
gastro-resistant tablets (28)
£4.69
Lamotrigine
50mg
tablets (56)
£5.58
Olmesartan / medoxomil
10mg
tablets (28)
£4.70
Olmesartan / medoxomil
20mg
tablets (28)
£3.94
Olmesartan / medoxomil
40mg
tablets (28)
£12.95
Pregabalin
25mg
capsules (56)
£4.20
Pregabalin
75mg
capsules (56)
£5.32
Pregabalin
300mg
capsules (56)
£7.84
5mg
tablets (28)
£1.43
Senna
7.5mg/5ml
oral solution sugar free (500ml)
£6.99
Trimethoprim
100mg
tablets (28)
£3.15

Do these prices reflect what you've paid so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel